Matthew Ronsheim

Insider Reports History

Entity
Individual
Location
35 Gatehouse Drive, Waltham, MA
Signature
/s/ Matthew Ronsheim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Ronsheim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Innoviva, Inc. Officer Common Stock 40.5K $653K $16.13 May 20, 2024 Direct
Innoviva, Inc. Officer Non-statutory Stock Option 120K Mar 5, 2024 Direct
Innoviva, Inc. Officer Nonqualified Stock Option 93.1K Jan 18, 2024 Direct
Entasis Therapeutics Holdings Inc. Chief of Pharma Sciences & MFG Common Stock 0 $2.20 Jul 11, 2022 Direct
Entasis Therapeutics Holdings Inc. Chief of Pharma Sciences & MFG Stock Option (right to buy) 0 Jul 11, 2022 Direct

Insider Reports Filed by Matthew Ronsheim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INVA Innoviva, Inc. May 20, 2024 1 -$4.32K 4 May 21, 2024 Officer
INVA Innoviva, Inc. Mar 5, 2024 2 $190K 4 Mar 7, 2024 Officer
INVA Innoviva, Inc. Feb 20, 2024 1 -$12.8K 4 Feb 22, 2024 Officer
INVA Innoviva, Inc. Jan 18, 2024 2 -$25.7K 4 Jan 22, 2024 Officer
INVA Innoviva, Inc. Jan 1, 2024 0 $0 3 Jan 10, 2024 Officer
ETTX Entasis Therapeutics Holdings Inc. Jul 7, 2022 6 -$38.7K 4 Jul 11, 2022 Chief of Pharma Sciences & MFG
ETTX Entasis Therapeutics Holdings Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 Chief of Pharmaceutical Sciences and Manufacturing
ETTX Entasis Therapeutics Holdings Inc. Nov 2, 2021 1 -$10.8K 4 Nov 3, 2021 Chief, Pharma Sciences & MFG.
ETTX Entasis Therapeutics Holdings Inc. Oct 19, 2021 2 -$12K 4 Oct 20, 2021 Chief of Pharmaceutical Sciences and Manufacturing
ETTX Entasis Therapeutics Holdings Inc. Jul 16, 2021 2 $0 4 Feb 15, 2022 Chief of Pharmaceutical Sciences and Manufacturing